Amgen Inc

AMGN

Equity

ISIN US0311621009 / Valor 907582

NASDAQ (2024-09-17)

USD 332.80-0.73%

Amgen Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

s a leading biotechnology company that focuses on addressing high unmet medical needs by developing innovative medicines to improve health outcomes and enhance the lives of patients worldwide. With a strong emphasis on science and innovation, Amgen leverages its expertise in understanding the biological mechanisms of disease to drive its discovery research efforts and build a deep pipeline of potential new medicines with breakthrough potential. Through its subsidiary deCODE Genetics, Amgen utilizes human genetics to identify and validate disease targets, further enhancing its research capabilities. As a global leader in biologics manufacturing, Amgen ensures the safe and reliable production of biologic medicines that are crucial for the treatment of millions of seriously ill patients. With a commitment to quality control and a reliable supply of medicines, Amgen's mission is to transform new ideas and discoveries into life-changing therapies for patients with serious illnesses.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

27.6%1Y

51.7%3Y

69.2%5Y

Performance

24.4%1Y

22.0%3Y

25.6%5Y

Volatility